•

EQUINE ANESTHESIA
Lyon Lee DVM PhD DACVA

Introduction
• Higher morbidity and mortality associated with general anesthesia (1:100) in comparison
to small animals (1:1000) or human (1: 200,000)
• No change of the risk ratio for the last 30 years, but the duration of surgery extended.
• Unique anatomic and physiologic characteristics presents additional challenge
• More pronounced cardiovascular depression (hypotension and reduced cardiac output) at
equipotent MAC than other species such as dogs and cats
• The size, weight temperament and tendency to panic of the adult horse introduce the risk
of injury to the patient and to the personnel.
• Prolonged recumbency is unnatural in the horse
• When a horse is placed in dorsal recumbency, the weight of the abdominal contents
presses on the diaphragm and limits lung expansion, leading to hypoventilation. If the
drugs used to produce anesthesia depress cardiovascular function, these changes will be
exaggerated due to a ventilation-perfusion mismatch.

Standing chemical restraint and preanesthetic agents

• Due to higher risk associated with general anesthesia in this species, standing chemical
restraint can offer safer alternative for many procedures
• Neuroleptanalgesia (neuroleptics + opioids) or sedative/opioid combination are most
popular
• Produced by the concurrent administration of a sedative/tranquilizer and a narcotic
analgesic (e.g. detomidine and butorphanol; acepromazine and morphine)
• Better restraint and analgesia (the combination is synergistic, not merely additive)
• Many procedures can be performed which would not be possible with the tranquilizer or
sedative alone
• Dose sparing effect on both drugs
• Better cardiovascular preservation
• Can provide satisfactory working condition for minor surgery when combined with local
anesthesia
• Less expense, less risk, less logistics
• This combination can also be effective as preanesthetic medication to produce reliable
sedation (e.g. xylazine and butorphanol combination)
• A good preanesthetic sedation facilitate smooth induction and has anesthetic sparing
effect during maintenance

Acepromazine
• Major tranquillizer

Equine Anesthesia 1 of 15
 • Hypotensive
• Anti-arrhythmic
• Stallion: penile priapism
• Requires at least 20 min for good effect even after IV injection, and 30 to 45 min when
given IM
• Prolonged duration
• 0.025 – 0.05 mg/kg
• Premedication dose of 0.04 mg/kg IV has minimal cardiovascular effect in healthy horses
• Respiratory rate decreases but tidal volume increases to maintain relatively normal
ventilation
• Will cause hypotension (more so in old, debilitated, or hypovolemic horses) through
direct myocardial depression and peripheral vasodilation
• Has been replaced mainly by alpha 2 agonists for sedation

Diazepam
• Minor tranquillizer
• Excellent muscle relaxation
• Minimal cardiopulmonary depression
• Not given alone in the horse due to panic ( and excitement) mediated by ataxia
• Usually administered as part of induction agents with ketamine
• 0.02 – 0.1 mg/kg IV

Xylazine
• Has replaced acepromazine as sedative/premedicant
• Onset of action following IV injection at 2 min, reaching peak effect in 5 minutes.
• Potent hypnotic and produces a predictable sedation
• Head drops almost to ground
• Beware, horses are very sensitive to touch on the hindlimbs when sedated with xylazine,
and still able to kick accurately
• Dose dependent severe cardiovascular effect: bradyacardia, AV dissociation, myocardial
depression (decreased cardiac output)
• Second degree atrioventricular heart block may persist for the duration of sedation.
• Initial transient hypertension lasting for 5 – 10 minutes, then prolonged hypotension
lasting 30 minutes or longer
• Little effect on respiration: PaO2 mildly fall
• Duration for sedative effect lasts about 30 minutes
• 0.5 - 1 mg/kg IV
• Horse becomes ataxic but remains standing
• Increasing dose does not increase the degree of sedation, but duration. (ceiling effect on
the degree of sedation)
• Best given with butorphanol for standing chemical restraint
• An intra-arterial injection of xylazine will usually cause uncontrolled excitement,
followed by collapse and thrashing or rigidity. This should be treated with an infusion of
guaifenesin to produce relaxation, diazepam to control seizures, oxygen to counteract
respiratory depression, fluids IV to counter hypotension.
• Other side effects
o Hyperglycemia
o Diuresis
o Sweating
o GIT motility depression

Equine Anesthesia 2 of 15
 o Depressed intestinal motility will last longer than the sedative effects of the drugs. Do
not feed the horse until intestinal motility returns, otherwise the horse may become
colicky
o Platelet aggregation
o Uterine contractions in cows. The incidence of abortion in pregnant mares has not
been established. Detomidine in this regard has been regarded better alternative both
in cows and mares.

Detomidine
• More popular in Europe (cheaper than xylazine)
• Duration of sedation longer acting than xylazine (twice), lasting at least 45 min
• 5 - 20 mcg/kg IV
• Similar side effects in all other aspects with xylazine
• Precautions are similar to those given for xylazine. Sedation may be inadequate if horse
was excited before administration of detomidine.

Romifidine
• Available in Europe for a while and recently become available in the US market
• Less ataxia may be advantageous for head and neck procedures
• 50 – 150 mcg/kg IV
• Longer sedative effect than detomidine
• Similar in all other aspects with xylazine and detomidine

Butorphanol
• Not used alone due to excitement, so always given with sedatives as part of
sedative/opioid combination
• Also, do not use morphine, oxymorphone, or etorphine alone in healthy horses.
(excitement can be even more pronounced)
• However, the horse in pain, e.g. colic, usually will not become excited when these drugs
are used in low doses for analgesia.
• Adequate analgesia for minor procedure
• 0.02 – 0.05 mg/kg IV
• Minimal change in HR, BP, CO when given alone.
• BP is decreased if butorphanol is administered during halothane anesthesia.

Anticholinergics
• Depress gastrointestinal motility and increase the risk of abdominal discomfort or colic,
so only administer when bradycardia or vagal reflexes are a problem
• Bradycardia in anesthetized horses is arbitrarily defined as HR < 25 beats/min
• Atropine 0.002 - 0.01 mg/kg IV or glycopyrrolate 0.001 – 0.005 mg/kg IV

Drug combinations
• Precaution on combining xylazine with acepromazine because of the additive
hypotensive effect
• More consistent degree of sedation and extended duration with the combination are
advantageous
• Experimentally, it has been demonstrated that simultaneous administration of
acepromazine (0.05 mg/kg) and xylazine (0.55 mg/kg) to healthy horses did not produce
cardiovascular changes that were significantly different from those produced by xylazine
alone at 1.1 mg/kg.

Equine Anesthesia 3 of 15
Preanesthetic Preparation
• No grain is to be fed 24 hours before anesthesia. No hay is to be fed 12 hours before
anesthesia.
• Water is OK
• Foals scheduled for general anesthesia are usually allowed to nurse up to 1 hour before
scheduled induction time
• Laboratory evaluation (minimum are PCV, TP, BUN, glucose)
• Additional tests may be warranted if sick and carries higher risks
• Review patient’s medical history; check for deworming dates. Wait at least one week,
preferably two, following organophosphate treatment.
• Do a physical examination to determine any abnormalities. Auscultate for cardiac
dysrhythmias and murmurs, or abnormal lung sounds.
• Stabilize animal’s physiology in debilitated animals (e.g. colic, ruptured bladder)
• IV catheterization in place
• A 12-14 gauge 3 – 5 inch long catheter is used for most horses.
• Pick the feet and clean the debris and dirt or cover the shoes
• Rinse the mouth with warm water prior to induction
• The mouth is washed out thoroughly using a dose syringe and water. This is done to
prevent the endotracheal tube carrying food material into the trachea and lungs.

Mouth rinsing

IV catheterization

Equine Anesthesia 4 of 15
ANESTHETIC INDUCTION
Critical for the safety both for the horse and the personnel, so smooth induction
is essential
• Techniques to induce:
o Swing door
o Free fall
o Hydraulic table

Most Common Anesthetic Drug Combination for Induction

• Xylazine premedication and ketamine (±diazepam) Induction
• Ketamine administered alone without sedative premedication to the horse causes
excitement
• Ketamine is injected 3-5 min after apparent xylazine induced sedation
• Ketamine is not used by IM injection in the conscious horse because the horse may be
injured during the period of incoordination occurring while the drug is taking effect
• Biologic half life of ketamine is 45 minutes in the horse, with 99% of a bolus dose
eliminated in 4 hours. Recovery to consciousness is due to extensive extravascular
distribution of the drug
• Induction of anesthesia occurs about 60 seconds after ketamine injection. Horse falls to
the ground characteristically with the forelimbs buckling and the hindlimbs straight. The
person holding the horse’s head should exert steady backward pressure on the horse
during loss of consciousness in an attempt to make the horse sit on its hindquarters and
not fall on its nose.
• Xylazine-ketamine anesthesia is accompanied by strong muscle tone for the first 5
minutes, and usually nystagmus, a strong palpebral reflex, and pupillary dilation.
• The duration of anesthesia varies from 7 min to 20 min. Anesthesia is often short in
young horses and in Thoroughbreds.
• The major advantage of this combination is that recovery is usually smooth, with less
incoordination than is seen with thiobarbiturate or guaifenesin combinations. The horse is
usually standing 30-40 minutes following a single administration of xylazine and
ketamine.
• Glyceryl Guaicolate Ether (GGE) is another useful drug for equine anesthetic induction
• Also known as guaifenesin (US) or guaiphenesin (Europe), it is administered at 50 – 100
mg/kg IV to effect to produce sedation/muscle relaxation
• Because of its muscle relaxant effect, this drug alone is not suitable to produce sedation
as the ataxic horse may panic

Equine Anesthesia 5 of 15
 • When animal knuckles following adequate dose (usually 50 mg/kg), a rapid bolus dose of
0.5 mg/kg ketamine IV or 2 mg/kg thiopental sodium is administered to provide smooth
anesthetic induction
• Anesthesia can then be maintained either on inhalational agent or intravenous anesthetics.
• Available in 5, 10, 15 % in commercial preparation, but concentration higher than 15 %
is not recommended for use due to hemolysis.
• Can be mixed with thiopental sodium, ketamine or xylazine in the diluent
• Home-made GGE may form precipitates if left unused for prolonged period, but
rewarming the diluent will resolve this, and the efficacy of the agent is not altered. This
problem is not seen with commercial preparations.
• Variations (see the chart below)
o Substitute xylazine with detomidine or romifidine
o Add butorphanol to premed
o Add acepromazine to premed
o Add diazepam to induction
o Add/substitute guaifenesin ± thiopental to induction
o Add/substitute Telazol, detomidine to induction (TKD mixture)

Xylazine
Detomidine
Romifidine

Butorphanol Acepromazine

Ketamine GGE Telazol

Diazepam Ketamine Thiopental Detomidine &

Ketamine (TKD)

Equine Anesthesia 6 of 15
Endotracheal Intubation
Relatively easy and carried out blindly
• No forcing, but rather smooth fit
• Check the cuff for leaks but maintain clean tube
• Apply KY jelly at the outside of the tip end of the ETT using a gauze sponge or paper
towel. This lubrication will facilitate the intubation.
• Modified PVC mouth gas is useful to facilitate the intubation

Endotracheal tube sizes based on weight

Horse weight 70-100 kg 150-200 kg 250 kg 350 kg 450 kg
Endotracheal
15-18 mm 18-22 mm 22-24 mm 24-26 mm 26-30 mm
tube size ID

Equine Anesthesia 7 of 15
Maintenance of Anesthesia
Mostly carried out using inhalants, but intravenous techniques can be used for
a short anesthetic

Inhalational anesthesia
• Problems occur more frequently and in greater magnitude than during canine anesthesia
• More pronounced hypotension, hypoventilation, reduction of cardiac output
• More dramatic consequence to the operator and the patient if anesthetic plane is not well
controlled
• Halothane, isoflurane, sevoflurane, desflurane recovery differ. The fasted recovery may
not be the best quality

Nitrous oxide
• Analgesia from N 2 O reduces inhalational anesthetic requirement therefore less
cardiovascular depression.
• However, even with 50 % oxygen and 50 % nitrous oxide mixture hypoxemia is common
probably due to the nitrous oxide dissolving into gaseous space such as GIT and leading
to the V/Q mismatches.
• Use of this agent is not recommended in this species (exception is foals and small-sized
equids)

Halothane (Fluothane®)
• Halothane has the highest metabolism, so avoid in hepatic insufficiency
• Currently it is not marked in the US, but some equine practices still carry it in their
inventroy
• This agent is being largely displaced by newer agent such as sevoflurane and isoflurane
as the cost of the newer agents becomes more affordable, however some equine
practitioners use it other than cost reason, mainly for superior recovery quality
(particularly important for orthopedic cases)
• 1 MAC halothane in horses is 0.9%, and 0.7 % in foals
• Always administered via endotracheal tube after induction of anesthesia with injectable
drugs.
• Halothane decreases ventilation. RR may be normal or decreased but arterial carbon
dioxide levels increase and oxygen levels decrease.
• Halothane sensitize the myocardium to circulatory catecholamines with more frequent
dysrhythmias exhibited
• A lightly anesthetized (1 MAC), spontaneously breathing horse will have a 40-50%
decrease in CO
• Heart rate is maintained in the normal range (28 to 44 beats/min)
• The arterial blood pressure decreases from conscious value (MAP 110) to 80 mmHg
• As anesthesia is deepened by increasing halothane concentration, CO and arterial
pressure decrease further. HR usually remains constant.

Equine Anesthesia 8 of 15
 Isoflurane (Aerrane®, Forane®, IsoFlo®)
• Used to be much more expensive than halothane, but the price has come down
substantially for the past few years, so more frequently used
• Quicker anesthetic stabilization and more rapid recovery
• However, in some recovery from anesthesia to consciousness is too quick leading to
poorer quality. Sedation with a minute dose (0.2 mg/kg) of xylazine has been
recommended to provide better recovery in some orthopedic procedures.
• 1 MAC in horses is 1.3%, and 0.9%. in foals
• The degree of respiratory depression is greater with isoflurane than halothane.
• As anesthesia deepens, the respiratory rate tends to increase with halothane and decrease
with isoflurane.
• Controlled ventilation (IPPV) is recommended for isoflurane anesthesia
• Isoflurane, similar to halothane, induces a dose-dependent cardiovascular depression.
• Little difference in cardiovascular function has been noted between halothane and
isoflurane when horses are breathing spontaneously.
• Under controlled ventilation, the cardiac output has been demonstrated to be significantly
higher during isoflurane anesthesia.
• Isoflurane causes more peripheral vasodilation than halothane, which is responsible for a
low arterial blood pressure, but tissue looks more bright and pinky indicating better
perfusion.

Sevoflurane (Ultane®)
• Anesthetic induction, recovery, and intraoperative modulation of anesthetic depths to be
notably faster than halothane and isoflurane.
• More expensive than halothane and isoflurane, but the price is getting lower.
• Sevoflurane (1 MAC = 2.3 %) is less potent than halothane or isoflurane, but more potent
than desflurane
• Sevoflurane induces dose-dependent cardiovascular depression to a degree similar to that
of isoflurane
• Sevoflurane and isoflurane cause greater increases in PaCO 2 , decreases in pH and
ventilatory response to hypercapnia than does halothane in horses. Respiratory rate is
lower than with halothane, and minute ventilation decreases
• Two sevoflurane breakdown products are of potential concern because of their
nephrotoxicity: Compound A and inorganic fluoride.
• No clinical studies of humans demonstrate significant changes in BUN, creatinine, or the
ability to concentrate urine after sevoflurane anesthesia when compared to other inhalant
anesthetics. This is true also for a study in horses
• Currently, more than 90 % of BVMTH equine cases are anesthetized with sevoflurane
• The recovery quality may suffer due to rapid emergence from anesthesia, hence sedating
with 0.2 mg/kg of xylazine at the time to move to the recovery stall may help

Equine Anesthesia 9 of 15
 Desflurane (Suprane®)
• Lower blood/gas partition coefficient than the inhalants mentioned above, so control of
anesthetic depth is relatively quick
• Horses’ recovery from desflurane anesthesia is fast (e.g. 15 min to standing after 100
minutes of anesthesia), and quality rated good to excellent
• The least potent among the volatile anesthetics in clinical use (MAC = 7.6 %)
• Cardiovascular effects of desflurane are similar with those of isoflurane
• Causes dose-dependent respiratory depression, the magnitude similar to isoflurane
• May cause airway irritation with resulting coughing, secretions and breath holding
• Expensive as sevoflurane, and requires electronically controlled vaporizer which adds to
the inconvenience

Total Intra-venous Anesthesia (TIVA)

• Xylazine 1.1 mg/kg premedication and ketamine 2.2 mg/kg induction provides
approximately 10 - 20 minutes of general anesthesia.
• Prolongation of xylazine-ketamine anesthesia in horses is done with 0.35 mg/kg of
xyalzine and 0.7 mg/kg IV of ketamine starting 12 minutes after the initial ketamine
induction. This dose can be repeated each 12 minutes for additional two doses, but
accumulative prolonged recovery maybe seen.
• Additional one fifth dose of induction agent provide a buying time until increased vapor
setting deepens anesthetic depth in the event animal suddenly wakes up during inhalation
maintenance anesthesia
• Alternatively,
o Xylazine and ketamine added to a bottle of guaifenesin (GKX) is very popular for
procedures not extending beyond 1 hour and administered as a continuous infusion.
o In 50 g of 1 L GGE, add 500 mg of xylazine and 2000 mg of ketamine and administer
1 – 3 ml/kg/hr depending on the CNS reflexes of the animal as assessed by ocular
reflex (brisk palpebral reflex, occasional nystagmus must be present), changes of
breathing pattern and rate, and changes of BP, HR etc.
o Given IV, not IM and never just for sedation
o Any procedure which is anticipated to last longer than 1 hour should not be done with
GGE-xyalzine/ketamine or GGE-barbiturate anesthesia alone. Prolonged recovery for
extended anesthesia
• Limitations:
• The main limitation to continued administration of intravenous anesthetics is the arterial
oxygenation.
• While it is true that progressive collapse of the down lung occurs with time, thus
increasing the ventilation-perfusion mismatch and decreasing arterial oxygenation, this
can be an unreliable guideline. One horse can be anesthetized and breathing air for an
hour or more and have acceptable levels of oxygen and carbon dioxide, whereas another
horse will become hypoxemic within 10 minutes.
• IV anesthesia should not be prolonged beyond 45 minutes in an adult horse without
supplying the horse with oxygen to breathe and means of ventilatory support
• Propofol: non-accumulative but very expensive
• Propofol and medetomidine combo (0.1 mg/kg/min of propofol and 3.5 mcg/kg/hr of
medetomidine) provides satisfactory anesthetic plane in response to supramaximal
noxious stimuli, and recovery in 4 hr + anesthesia was very smooth, rapid and complete
• Tight anesthetic depth control is harder with TIVA so abrupt awakening during
anesthesia is more likely if one is not familiar with the technique (inhalant anesthetic
provides advantage in this respect as by monitoring anesthetic concentration in breathing
gases, one can control anesthetic depth better)
Equine Anesthesia 10 of 15
 The following table lists some sample doses for injectable anesthetics in the horses
Dose Dose
Comb. # Premedication Induction agents
mg/kg mg/kg
1 Xylazine 1 Ketamine 2
Xylazine 0.7 Diazepam 0.05
2
Ketamine 2
Xylazine 1 Ketamine 2
3
Butorphanol 0.02
Xylazine 0.5 Diazepam 0.05
4
Butorphanol 0.02 Ketamine 2
Acepromazine 0.04 Ketamine 2
5
Xylazine 0.6 to 1.1
Xylazine 0.6 to 1.1 Guaifenesin 100 (G)
6 followed by or “to effect”
ketamine bolus 1 (K)
Acepromazine 0.04 Guaifenesin 50 g 100 (G) – 4 (T)
or Xylazine 0.6 mixed with 2 g or “to effect”
7
thiopental followed
by thiopental bolus 2 (T)
Acepromazine 0.04 Guaifenesin 50 g 100 (G) – 4 (T)
or Xylazine 0.6 mixed with 2 g or “to effect”
8
± Butorphanol 0.02 thiopental followed
by thiopental bolus 2 (T)
Detomidine 0.01 Guaifenesin 50 g 100 (G) – 4 (T)
± Butorphanol 0.02 mixed with 2 g or “to effect”
9
thiopental followed
by thiopental bolus 2 (T)

Equine Anesthesia 11 of 15
Monitoring
• Potentially life-threatening values
o HR < 24 beats/min
o MAP < 60 mm Hg
o RR < 4 breaths/min
• Evaluation of CNS
o Eyeball position (central), pupil size, palpebral reflex (sluggish), corneal reflex
(strong)
o Nystagmus can be present, but usually indicates light plane (exception: dissociative
drugs)
o Lack of movement in response to surgery, muscle relaxation
• Evaluation of CVS
o Palpation of peripheral arterial pulse
quality, rhythm
o CRT
o Evaluation of blood loss
• Evaluation of Respiratory system
o Color of mucous membrane
o Characteristics of breathing pattern
• ECG
• Blood pressure
o Direct measurement always if
possible
o Maintain MAP above 60 mmHg, or
70 mmHg in heavy muscled breeds
o Dobutamine at the rate 1 – 5 mcg/kg/min very effective for inotropic support
(remember tissue perfusion depends both on BP and flow)
• Capnography
o Very useful for controlled ventilation
• Arterial blood gas (ABG) analysis
o Provides direct assessment of ventilatory efficiency
o Also modern ABG analyzers come with features to measure electrolytes and acid
base status.

Equine Anesthesia 12 of 15
Recovery
• The incidence of recovery associated complication is higher than other domestic species
• Airway obstruction is a concern: nasal edema can easily develop in dorsal recumbency
and then cannot breathe after extubation
• Nasal spray of vasocontrictors (e.g. phenylephrine) are commonly applied, or
alternatively nasal intubation is performed to secure patent airway (NB. make sure it is
well secured to the animal’s head/collar using tapes as loose tube may fall into the
trachea during the recovery and may cause fatal airway obstruction)
• Supply with high flow oxygen during
recovery (> 15 L/min)
• Demand valve can be used to give high
flow oxygen and adequate tidal volume
so as to assist ventilation to prevent
hypoxemia
• Animals with preexisting neurologic
signs (ataxia), rhabdomyolysis (tying-
up), and lineage of hyperkalemic
periodic paralysis (HYPP) predisposed
breeds would require extra care and
precautions.
• The horse should not be fed for several
hours after anesthesia, and grain
withheld until the following day
• Fast recovery not always the safest nor
best in quality: adequate sedation may
be indicated to calm the animal and
avoid stimulation
• Quiet and dark room is preferred
• In horses trying to stand up too quickly
and yet with poor muscle coordination
may predispose to fracturing limbs or
other types of injury. Recovering in
padded stall can minimize the impact.
• Assisted or hand recovery maybe useful
in foals or manageable horses.
• Head and tail ropes maybe useful to support the recovery in severely ataxic horses.

Equine Anesthesia 13 of 15
Post-anesthetic complications
• One of the major risks associated with equine general anesthesia is “post anesthetic
myopathy”
• Myopathy or nerve damage in the limbs sometimes develops following general
anesthesia as a result of ischemia or pressure damage.
• Most common form is ischemia of shoulder muscles or hindquarters resulting in lameness
or inability to stand
• The horse cannot stand or will have difficulty in standing. Horses that were in lateral
recumbency are most frequently lame in the dependent forelimb and/or hind limb
• Lameness is not always present immediately after the horse stands, but may develop 1-2
hours later.
• Post anesthetic myopathy prevention
• Positioning of limbs: lower forelimb forward, upper limbs elevated and supported, lower
hind limb backward
• Foam pads, air mattress, water bed
• Maintain mean arterial pressure above 60-70 mm Hg
• Treatment of post-anesthetic myopathy
o Pain management and anti-inflammatory agents (NSAID, Corticosteroids)
o Fluid therapy
o Diuresis
o Calcium
o Sling and rope to support the torso
o Physical therapy (gentle massage)
o Positive inotropes to maintain CO and BP
o If not responsive to the Tx within days, and the symptom deteriorates causing severe
distress and pain to the animal, euthanasia maybe the only option.

Equine Anesthesia 14 of 15
Case Example
COLIC
Significance on
Problem Plan
Potential Complication
CNS depression Decreased dosage, Reduce the calculated dose
hypoventilation rates, controlled ventilation
Hypovolemia Hypotension Fluids before anesthesia
Abdominal distension Hypotension, Decompress before
hypoventilation anesthesia, controlled
ventilation
Metabolic acidosis Hypotension, decreased Give sodium bicarbonate
dosage, prolonged recovery before anesthesia if pH <
7.2 and deficit > 10
Azotemia Decreased dosage, Use less than the usual
prolonged recovery, post- calculated dose rates,
operative renal failure dopamine infusion during
anesthesia
Hypocalcemia Hypotension Give calcium
Dysrhythmias Hypotension, cardiac arrest Treat dysrhythmias, support
CV function
Pain Increased sympathetic Provide analgesics eg,
activity xylazine, butorphanol,
flunixin meglumine etc.

Signalment “Karma” 5 y.o. Female Quarter horse weighing 450 Kg

History colicky for 24 hrs
Physical examination HR 80, RR 40, Temp: 103, weak pulse on palpation, distended
abdomen, decreased GIT motility, depressed
Laboratory evaluation PCV 60, TP 10, BUN 25-35, glucose 130, PaO 2 60, PaCO 2 25,
pH 7.25, HCO 3 - 16, Na+ 140, K+ 5, Ca+ 1.02, Cl- 95
Patient preparation Fluids: Normosol 40 ml/kg IV reassess PCV TP and
electrolytes, and physical exam
Induction Lower dose
Xylazine 0.8 mg/kg + butorphanol 0.02 mg/kg
Ketamine 2mg/kg + diazepam 0.02 mg/kg
Maintenance Sevoflurane in oxygen
Monitoring ECG, Capnography, Direct arterial blood pressure,
Temperature, Arterial blood gas and electrolytes, blood loss,
CRT, ocular reflexes etc.
Recovery Quiet, dark and warm environment
Oxygen supplementation and ventilatory support using demand
valve
Sedation with 0.2 mg/kg xylazine
Small nasal tube to secure patent airway after extubation
uneventful

Equine Anesthesia 15 of 15